Jack Allen
Stock Analyst at Baird
(0.59)
# 2459
Out of 5,372 analysts
50
Total ratings
40.74%
Success rate
-3.86%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
FATE Fate Therapeutics | Maintains: Neutral | 5 4 | 1.19 | 236.13% | 2 | May 14, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Outperform | 12 9 | 1.3 | 592.31% | 3 | May 14, 2025 | |
CARM CARISMA Therapeutics | Downgrades: Neutral | 10 1 | n/a | n/a | 3 | Dec 12, 2024 | |
INKT MiNK Therapeutics | Maintains: Outperform | 80 40 | 7.31 | 447.2% | 2 | Nov 15, 2024 | |
VOR Vor Biopharma | Maintains: Outperform | 22 14 | n/a | n/a | 3 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 77 106 | 62.93 | 68.44% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 18 | 9.58 | 87.89% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 180 180 | 27.8 | 547.48% | 9 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 140 120 | n/a | n/a | 3 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 8 | 2.8 | 185.71% | 1 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 52 | 43.19 | 20.4% | 2 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 84 | 32.39 | 159.34% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 200 25 | n/a | n/a | 3 | Sep 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 8 | 2.58 | 210.08% | 4 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 21 6 | n/a | n/a | 2 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 5 | 0.86 | 481.4% | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 9 | n/a | n/a | 1 | Sep 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | n/a | n/a | n/a | 2 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 6 9 | 3.11 | 189.39% | 1 | Oct 7, 2021 |